| Issue | Title | |
| Vol 1, No 4 (2005): September/October | Methadone-related deaths | Abstract PDF |
| Lynn R. Webster, MD | ||
| Vol 5, No 6 (2009): November/December | Methylnaltrexone potentiates body weight and fat reduction with leptin | Abstract |
| Chun-Su Yuan, MD, PhD, Shi Sun, PhD, Anoja Attele, MD, Chong-Zhi Wang, PhD, Robin Tong, BS, Robert J. Israel, MD | ||
| Vol 5, No 4 (2009): July/August | Methylnaltrexone reduced body weight gain in ob/ob mice | Abstract |
| Chun-Su Yuan, MD, PhD, Chong-Zhi Wang, PhD, Anoja Attele, MD, Liu Zhang, PhD | ||
| Vol 5, No 4 (2009): July/August | Midazolam as an antiemetic in patients receiving epidural morphine for postoperative pain relief | Abstract |
| Mokhtar Elhakim, MD, Hany Abd Elfattah, MD, Dalia Nasr El-Din, MD, Reem El-Kabarity, MD, Azia Atef, MD, Atef El-Fakey, MD | ||
| Vol 12, No 1 (2016): January/February | Minimizing stress with remifentanil in a patient with Takotsubo undergoing ophthalmic surgery | Abstract |
| Sbaraglia Fabio, MD, Garra Rossella, MD, De Riso Mariella, MD, Continolo Nicola, MD, Sammartino Maria, MD | ||
| Vol 2, No 3 (2006): May/June | Modafinil: Is it ready for prime time? | Abstract PDF |
| Eric Prommer, MD | ||
| Vol 1, No 5 (2005): November/December | Monitoring outcomes during long-term opioid therapy for noncancer pain: Results with the Pain Assessment and Documentation Tool | Abstract PDF |
| Steven D. Passik, PhD, Kenneth L. Kirsh, PhD, Laurie Whitcomb, MA, Jeffrey R. Schein, PhD, MPH, Mitchell A. Kaplan, PhD, Sheri L. Dodd, MSc, Leah Kleinman, PhD, Nathaniel P. Katz, MD, Russell K. Portenoy, MD | ||
| Vol 10, No 1 (2014): January/February | Monitoring oxycodone use in patients with chronic pain: Analysis of oxycodone and metabolite excretion in saliva and urine | Abstract |
| Kathleen V. Moy, MS, Joseph D. Ma, PharmD, Candis M. Morello, PharmD, CDE, Rabia S. Atayee, PharmD, BCPS, Brookie M. Best, PharmD, MAS | ||
| Vol 17, No 4 (2021): July/August | More than half of opioids prescribed to pediatric patients after ambulatory knee surgery are unused | Abstract |
| Pamela Wendel, MD, Danya DeMeo, BS, Madison R. Heath, BS, Alexandra T. Mackie, BA, PB-BS, Haoyan Zhong, MPA, Kathryn DelPizzo, MD, Kanupriya Kumar, MD, Peter D. Fabricant, MD, MPH | ||
| Vol 1, No 2 (2005): May/June | Morphine analgesia in cancer pain: Role of the glucuronides | Abstract PDF |
| Richard T. Penson, MRCP, MD, Simon P. Joel, PhD, Anna Gloyne, BSc, Simon Clark, BSc, Maurice L. Slevin, FRCP, MD | ||
| Vol 7, No 2 (2011): March/April | Morphine and cancer progression: Hydrogen peroxide points to need for more research | Abstract |
| Herbert Bosshart, MD | ||
| Vol 8, No 4 (2012): July/August | Morphine clearance in children: Does race or genetics matter? | Abstract |
| Senthilkumar Sadhasivam, MD, MPH, Elke H. J. Krekels, MSc, Vidya Chidambaran, MD, Hope R. Esslinger, MPT, Pornswan Ngamprasertwong, MD, Kejian Zhang, MD, MBA, Tsuyoshi Fukuda, PhD, Alexander A. Vinks, PharmD, PhD | ||
| Vol 3, No 1 (2007): January/February | Morphine prescription in end-of-life care and euthanasia: French home nurses’ opinions | Abstract PDF |
| Marc Karim Bendiane, PhDc, Anne-Deborah Bouhnik, PhDc, Roger Favre, PhD, Anne Galinier, MD, Yolande Obadia, MD, Jean-Paul Moatti, PhD, Patrick Peretti-Watel, PhD | ||
| Vol 1, No 1 (2005): March/April | Morphine prescription to terminally ill patients with lung cancer and dyspnea: French physicians’ attitudes | Abstract PDF |
| Marc K. Bendiane, MSC, Patrick Peretti-Watel, PhD, Herve Pegliasco, MD, Roger Favre, PhD, Anne Galinier, MD, Jean-Marc Lapiana, MD, Yolande Obadia, MD | ||
| Vol 2, No 3 (2006): May/June | Morphine toxicity in renal failure | Abstract PDF |
| Ferraz Gonçalves, MD | ||
| Vol 10, No 5 (2014): September/October | MT-45: A new, dangerous legal high | Abstract |
| Maurizio Coppola, MD, Raffaella Mondola, MD | ||
| Vol 17, No 5 (2021): September/October | Multimodal opioid sparing onco-anesthesia: A consensus practice guideline from Society of Onco-Anesthesia and Perioperative Care (SOAPC) | Abstract |
| Sohan Lal Solanki, MD, PDCC, MAMS, Raghu S. Thota, MD, MAMS, Jeson Rajan Doctor, MD, DNB, MNAMS, Gauri Raman Gangakhedkar, DNB, Parmanand Jain, MD, MAMS, Vijaya Gottumukkala, MD, Rakesh Garg, MD, Juan P. Cata, MD, Jyotsna Goswami, MD, Namrata Ranganath, MD, Seshadri Ramkiran, DA, DNB, Babita Ghai, MD, Keyuri U. Popat, MD, Donal J. Buggy, MD, Anjali A. Pingle, DNB, FRCA, Vaibhavi Baxi, DNB, Basanth Kumar Rayani, MD, Mary Thomas, DA, DNB, Sushma Bhatnagar, MD, Jigeeshu V. Divatia, MD, FCCM | ||
| Vol 16, No 6 (2020): November/December | Narcotic use in patients following a traumatic injury | Abstract |
| Audis Bethea, PharmD, BCPS, BCCCP, Damayanti Samanta, MS, Kellie Amodeo, MD | ||
| Vol 16, No 3 (2020): May/June | National gender differences in the prescribing of opioid medications from 2006 to 2015 | Abstract |
| Salena Marie Preciado, MS, Daniel Tomaszewski, PharmD, PhD, T. Craig Cheetham, PharmD, MS, Tania Gregorian, PharmD, Sharon Xavioer, PharmD, BCACP, Souhiela Fawaz, BPharm (Hons), PhD | ||
| Vol 5, No 1 (2009): January/February | Nebulized morphine for analgesia in an emergency setting | Abstract |
| Vincent Bounes, MD, Jean Louis Ducassé, MD, Annie Momo Bona, MD, Florent Battefort, MD, Charles-Henri Houze-Cerfon, MD, Dominique Lauque, MD | ||
| Vol 6, No 6 (2010): November/December | Neonatal abstinence scores in opioid-exposed and nonexposed neonates: A blinded comparison | Abstract |
| Hendrée E. Jones, PhD, Cheryl Harrow, RN-LRN, MS, FNP-BC, IBCLC, Kevin E. O’Grady, PhD, Michael Crocetti, MD, Lauren M. Jansson, MD, Karol Kaltenbach, PhD | ||
| Vol 1, No 1 (2005): March/April | News Briefs | Abstract PDF |
| Richard A. DeVito, Jr. | ||
| Vol 1, No 2 (2005): May/June | News Briefs | Abstract PDF |
| Richard A. DeVito, Jr. | ||
| Vol 1, No 3 (2005): July/August | News Briefs | Abstract PDF |
| Richard A. DeVito, Jr. | ||
| Vol 1, No 4 (2005): September/October | News Briefs | Abstract PDF |
| Richard A. DeVito, Jr. | ||
| Vol 1, No 5 (2005): November/December | News Briefs | Abstract PDF |
| Richard A. DeVito, Jr. | ||
| Vol 2, No 1 (2006): January/February | News Briefs | Abstract PDF |
| Richard A. DeVito, Jr. | ||
| Vol 2, No 2 (2006): March/April | News Briefs | Abstract PDF |
| Richard A. DeVito, Jr. | ||
| Vol 3, No 1 (2007): January/February | News Briefs | Abstract PDF |
| Richard A. DeVito, Jr. | ||
| Vol 3, No 2 (2007): March/April | News Briefs | Abstract PDF |
| Richard A. DeVito, Jr. | ||
| Vol 1, No 3 (2005): July/August | No potentiation of fentanyl by use of transdermal buprenorphine in patients undergoing fast-track anesthesia for open-heart surgery | Abstract PDF |
| Enno Freye, MD, PhD, Erhard Hartung, MD, Joseph Victor Levy, PhD | ||
| Vol 1, No 3 (2005): July/August | Novel Aspects of Pain Management: Opioids and Beyond | Abstract PDF |
| Robert L. Barkin, PharmD, MBA, FCP, DAPPM | ||
| Vol 12, No 4 (2016): July/August | Novel peer review method for improving controlled substance prescribing in primary care | Abstract |
| Brian Penti, MD, MS, Jane M. Liebschutz, MD, MPH, FACP, Brian Kopcza, PharmD, BCACP, Ziming Xuan, ScD, Christine Odell, MD, MSc, Robert Saper, MD, MPH | ||
| Vol 1, No 5 (2005): November/December | November/December 2005 | Abstract PDF |
| Richard A. DeVito, Jr. | ||
| Vol 2, No 6 (2006): November/December | NOVEMBER/DECEMBER 2006 | Abstract PDF |
| Richard A. DeVito, Jr. | ||
| Vol 3, No 6 (2007): November/December | November/December 2007 | Abstract |
| Richard A. DeVito, Jr. | ||
| Vol 4, No 6 (2008): November/December | November/December 2008 | Abstract |
| Richard A. DeVito, Jr. | ||
| Vol 5, No 6 (2009): November/December | November/December 2009 | Abstract |
| Richard A. DeVito, Jr. | ||
| Vol 6, No 6 (2010): November/December | NOVEMBER/DECEMBER 2010 | Abstract |
| Richard A. DeVito, Jr. | ||
| Vol 7, No 6 (2011): November/December | November/December 2011 | Abstract |
| Richard A. DeVito, Jr. | ||
| Vol 10, No 2 (2014): March/April | Observation of improved adherence with frequent urine drug testing in patients with pain | Abstract |
| David A. Yee, BS, Michelle M. Hughes, BA, Alexander Y. Guo, MS, Neveen H. Barakat, BS, Stephanie A. Tse, BS, Joseph D. Ma, PharmD, Brookie M. Best, PharmD, MAS, Rabia S. Atayee, PharmD, BCPS | ||
| Vol 6, No 4 (2010): July/August | Observations of medication compliance by measurement of urinary drug concentrations in a pain management population | Abstract |
| Robert West, MS, Amadeo Pesce, PhD, DABCC, Cameron West, PhD, Bridgit Crews, PhD, Charles Mikel, PhD, Murray Rosenthal, DO, FAPA, Perla Almazan, CLS, MT (ASCP), Sergey Latyshev, MS | ||
| Vol 10, No 3 (2014): May/June | Observations on hydrocodone and its metabolites in oral fluid specimens of the pain population: Comparison with urine | Abstract |
| Jennifer M. Cao, BS, Joseph D. Ma, PharmD, Candis M. Morello, PharmD, CDE, Rabia S. Atayee, PharmD, BCPS, Brookie M. Best, PharmD, MAS | ||
| Vol 8, No 3 (2012): May/June | Older adults’ postoperative pain medication usage after total knee arthroplasty: A qualitative descriptive study | Abstract |
| Samantha Bremner, MSc, Fiona Webster, PhD, Joel Katz, PhD, Judy Watt-Watson, PhD, Colin McCartney, MBChB | ||
| Vol 4, No 5 (2008): September/October | Onset of analgesic effect and plasma levels of controlled-release tramadol (Tramadol Contramid once-a-day) 200-mg tablets in patients with acute low back pain | Abstract |
| Adrian Sarbu, MD, Florin Radulescu, MD, Sybil Robertson, BScN, Sylvie Bouchard, MD, PhD | ||
| Vol 9, No 1 (2013): January/February | Open-label study to evaluate the efficacy and safety of extended-release hydromorphone in patients with chronic neuropathic pain | Abstract |
| Srinivas Nalamachu, MD, Donna Ruck, ARNP, Rahul Nalamasu, Sam Fasbinder, Ritvik Bansal | ||
| Vol 17, No 4 (2021): July/August | Opiate prescribing patterns in the adolescent population following anterior cruciate ligament reconstruction | Abstract |
| Alexander Karius, BS, Eli M. Cahan, BBA, Nicole A. Segovia, BS, Austin Fan, BA, Charles M. Chan, MD | ||
| Vol 1, No 3 (2005): July/August | Opiate replacement therapy at time of release from incarceration: Project MOD, a pilot program | Abstract PDF |
| Michelle McKenzie, MPH, Grace Macalino, PhD, Clair McClung, BS, David C. Shield, BS, Josiah D. Rich, MD, MPH | ||
| Vol 3, No 4 (2007): July/August | Opiates and opioids: What a difference a name makes | Details |
| Gary M. Reisfield, MD, Roger L. Bertholf, PhD, George R. Wilson, MD | ||
| Vol 3, No 1 (2007): January/February | Opioid administration for acute abdominal pain in the pediatric emergency department | Abstract PDF |
| Adi Klein-Kremer, MD, Ran D. Goldman, MD | ||
| Vol 14, No 4 (2018): July/August | Opioid analgesics prescription in people with and without cancer in France | Abstract |
| Asmaa Janah, PhD Candidate, Anne-Déborah Bouhnik, PhD, Sébastien Cortaredona, MSc, Julien Mancini, MD, PhD, Philippe Jean Bousquet, MD, PhD, Patrick Peretti-Watel, PhD, Marc-Karim Bendiane, MSc | ||
| Vol 1, No 4 (2005): September/October | Opioid contract use is associated with physician training level and practice specialty | Abstract PDF |
| Bryan Keith Touchet, MD, William Robert Yates, MD, Kim Annette Coon, EdD | ||
| Vol 7, No 1 (2011): January/February | Opioid delivery in the treatment of cancer breakthrough pain: A review of routes of administration | Abstract |
| Bruce Nicholson, MD, Sanjiv S. Agarwala, MD | ||
| Vol 16, No 1 (2020): January/February | Opioid dispensation among systemic lupus erythematosus patients who persistently frequent the emergency department | Abstract |
| Jiha Lee, MD, MHS, Lisa Gale Suter, MD, Liana Fraenkel, MD, MPH | ||
| Vol 17, No 1 (2021): January/February | Opioid epidemics during the pandemic: Further insights to the same story | Abstract |
| Amany E. Ayad, MD, FIPP | ||
| Vol 15, No 2 (2019): March/April | Opioid e-prescribing trends at discharge in a large pediatric health system | Abstract |
| Christopher M. Horvat, MD, MHA, Brian Martin, DMD, Liwen Wu, MS, Anthony Fabio, PhD, Phil E. Empey, PharmD, PhD, Fanuel Hagos, PhD, Sheila Bigelow, DO, Sajel Kantawala, BS, Alicia K. Au, MD MS, Patrick M. Kochanek, MD, Robert S. B. Clark, MD | ||
| Vol 13, No 3 (2017): May/June | Opioid management strategy decreases admissions in high-utilizing adults with sickle cell disease | Abstract |
| Amy Mager, PA-C, MPAS, Kristin Pelot, MSSW, Kathryn Koch, APNP, Lawrence Miller, PsyD, Collin Hubler, BS, Anisah Ndifor, BS, Canice Coan, PharmD, Cynthia Leonard, MSN, Joshua J. Field, MD, MS | ||
| Vol 1, No 1 (2005): March/April | Opioid management: Addressing the gap in understanding, education, and practice | Abstract PDF |
| Robert E. Enck, MD | ||
| Vol 15, No 3 (2019): May/June | Opioid overdose history and awareness of naloxone in patients seeking outpatient detoxification | Abstract |
| Saurabh B. Bhardwaj, MD, Gerald Cochran, PhD, Julie Kmiec, DO | ||
| Vol 13, No 6 (2017): November/December - Abuse Deterrent Opioids Special Issue | Opioid overdose protection: An inevitable need to address an alarming epidemic | Abstract |
| Beatrice Setnik, PhD | ||
| Vol 16, No 2 (2020): March/April | Opioid overdoses: Emerging clinical challenges | Abstract |
| Andrea Ramos, BSN, RN, MSPH, Lina Sarmiento, RN, Noella Dietz, PhD, Nelson Cordero, MD, Ximena Levy, MD-MPH, Charles H. Hennekens, MD, DrPH | ||
| Vol 9, No 6 (2013): November/December | Opioid overuse pain syndrome (OOPS): The story of opioids, Prometheus unbound | Abstract |
| Anand W. Mehendale, MD, Mark P. Goldman, PhD, Rachel P. Mehendale, BA | ||
| Vol 13, No 2 (2017): March/April | Opioid pain medication prescriptions obtained through emergency medical visits in the Veterans Health Administration | Abstract |
| Michael A. Grasso, MD, PhD, FACP, Zachary D. W. Dezman, MD, MS, Clare T. Grasso, PhD Candidate in Computer Science, David A. Jerrard, MD | ||
| Vol 9, No 3 (2013): May/June | Opioid prescribing knowledge and practices: Provider survey following promulgation of guidelines–Utah, 2011 | Abstract |
| Christina A. Porucznik, PhD, MSPH, Erin M. Johnson, MPH, Robert T. Rolfs, MD, MPH, Brian C. Sauer, PhD | ||
| Vol 17, No 1 (2021): January/February | Opioid prescribing trends: Changes after focused hospital resident education and after subsequent adoption of new state regulations | Abstract |
| Victoria Simmons, MD, Sejul Chaudhary, MD, Karen Hagglund, MS, R. David Hayward, PhD, Elango Edhayan, MD | ||
| Vol 17, No 2 (2021): March/April | Opioid prescription claims among women aged 15-44 years—United States, 2013-2017 | Abstract |
| April D. Summers, MPH, Elizabeth C. Ailes, PhD, Michele K. Bohm, MPH, Emmy L. Tran, PharmD, MPH, Cheryl S. Broussard, PhD, Meghan T. Frey, MPH, Suzanne M. Gilboa, PhD, Jean Y. Ko, PhD, Jennifer N. Lind, PharmD, MPH, Margaret A. Honein, PhD | ||
| Vol 15, No 6 (2019): November/December | Opioid prescription patterns among patients with fibromyalgia | Abstract |
| Caio V. M. Sarmento, PT, PhD, Mehrdad Maz, MD, Taylor Pfeifer, DPT, Marco Pessoa, PhD, Wen Liu, PhD | ||
| Vol 11, No 4 (2015): July/August | Opioid prescriptions before and after high-energy trauma | Abstract |
| Stine T. Zwisler, MD, PhD, Jesper Hallas, MD, PhD, Morten S. Larsen, MD, Gitte Handberg, MD, Soeren Mikkelsen, MD, Thomas P. Enggaard, MD, PhD | ||
| Vol 13, No 4 (2017): July/August | Opioid receptor antagonists in the treatment of pathological gambling | Abstract |
| Maurizio Coppola, MD, Raffaella Mondola, MD | ||
| Vol 11, No 3 (2015): May/June | Opioid regimens in patients with chronic pain with multiple cytochrome P450 defects | Abstract |
| Forest Tennant, MD, DrPH | ||
| Vol 1, No 2 (2005): May/June | Opioid Research: Methods and Protocols. | Abstract PDF |
| Mellar P. Davis, MD, FCCP | ||
| Vol 4, No 4 (2008): July/August | Opioid rotation in patients with cancer: A review of the current literature | Abstract |
| Athina Vadalouca, MD, PhD, FIPP, Eleni Moka, MD, Erifilli Argyra, MD, PhD, Panayiota Sikioti, MD, Ioanna Siafaka, MD, PhD | ||
| Vol 11, No 5 (2015): September/October | Opioid rotation: A case example using methadone in spinal cord injury | Abstract |
| Jayne Pawasauskas, PharmD, BCPS | ||
| Vol 2, No 4 (2006): July/August | Opioid safety | Abstract PDF |
| Robert E. Enck, MD | ||
| Vol 7, No 4 (2011): July/August | Opioid therapy for chronic pain: Physicians’ attitude and current practice patterns | Abstract |
| Lucy Chen, MD, Mary Houghton, BA, Lindsey Seefeld, BS, Charlene Malarick, BSN, RN, Jianren Mao, MD, PhD | ||
| Vol 9, No 5 (2013): September/October | Opioid therapy in children and adolescents: A physician's guide to risk assessment, monitoring, and mitigation of abuse | Abstract |
| Jessica Anne George, MD, Sabine Kost-Byerly, MD, Constance L. Monitto, MD | ||
| Vol 10, No 1 (2014): January/February | Opioid titration with sustained-release oxycodone and immediate-release morphine for moderate/severe cancer pain: A pilot assessment of the CoDem protocol | Abstract |
| Boaz Gedaliahu Samolsky Dekel, MD, PhD, MA, Marco Tomasi, MD, Alessio Vasarri, MD, Alberto Gori, MD, Marco Adversi, MD, Anna Castagnoli, MD, GianFranco Di Nino, MD, Rita Maria Melotti, MD | ||
| Vol 13, No 5 (2017): September/October | Opioid tolerance and urine drug testing among initiates of extended-release or long-acting opioids in Food and Drug Administration's Sentinel System | Abstract |
| Marc R. Larochelle, MD, MPH, Noelle M. Cocoros, DSc, MPH, Jennifer Popovic, DVM, MA, Elizabeth C. Dee, MPH, Cynthia Kornegay, PhD, Jing Ju, PharmD, PhD, Judith A. Racoosin, MD, MPH | ||
| Vol 11, No 2 (2015): March/April | Opioid treatment of experimental pain activates nuclear factor-κB | Abstract |
| Peggy Compton, RN, PhD, Charles Griffis, CRNA, PhD, Elizabeth Crabb Breen, PhD, Matthew Torrington, MD, Ryan Sadakane, BS, Eshetu Tefera, MS, Michael R. Irwin, MD | ||
| Vol 17, No 4 (2021): July/August | Opioid use disorder among hospitalized adults in North Carolina: Comparative analysis of national and statewide trends | Abstract |
| Brook T. Alemu, PhD, MPH, Emily A. McCague, MPH, Nicole Holt, DrPH, Patrick A. Baron, PhD, MSPH, Olaniyi Olayinka, MD, MPH, Brian C. Martin, PhD, MBA | ||
| Vol 14, No 3 (2018): May/June | Opioid use disorder and homelessness in the Veterans Health Administration: The challenge of multimorbidity | Abstract |
| Theddeus Iheanacho, MD, Elina Stefanovics, PhD, Robert Rosenheck, MD | ||
| Vol 17, No 5 (2021): September/October | Opioid use disorders national registries and opioids sales registries: A 10-year prevalence study from a middle-income country | Abstract |
| Daniela Yucumá, MD, Ana Beatriz Pizarro, RN, Diego Alberto Moreno, MD, Juan David Mosos, MD, Marian Rincón-Montaña, MD, Diego Rosselli, MD | ||
| Vol 12, No 2 (2016): March/April | Opioid use following the introduction of an extended-release oxycodone formulation with tamper-resistant properties: Prospective historical chart review in methadone-maintained patients | Abstract |
| Christopher Sankey, MD, CCFP (EM), Beatrice Setnik, PhD, Zoltan Harsanyi, BSc (Hon), MLS, MBA, PStat. (SSC), PSTAT® (ASA), Ken Michalko, PharmD, MBA, Zejiang Yang, PhD, Pierre Geoffroy, MDCM, MSc, FCFP, DABAM | ||
| Vol 14, No 3 (2018): May/June | Opioid use in the acute setting: A survey of providers at an academic medical center | Abstract |
| Douglas R. Oyler, PharmD, Kristy S. Deep, MD, Phillip K. Chang, MD | ||
| Vol 6, No 2 (2010): March/April | Opioid use in young veterans | Abstract |
| Phipson C. Wu, PharmD, BCPS, Courtney Lang, PharmD, BCPS, Noelle K. Hasson, PharmD, Steven H. Linder, MD, David J. Clark, MD | ||
| Vol 14, No 4 (2018): July/August | Opioid use: Case-control analyses of worker's compensation data | Abstract |
| Ulrike Ott, PhD, MSPH, Matthew S. Thiese, PhD, MSPH, Brenden B. Ronna, BS, Kristine Hegmann, MSPH, CIC, Kurt T. Hegmann, MD, MSPH | ||
| Vol 15, No 1 (2019): January/February | Opioid utilization patterns among patients with cancer and non-cancer pain | Abstract |
| Catherine J. Datto, MD, MS, Yiqun Hu, MD, PhD, Eric Wittbrodt, PharmD, MPH, Perry G. Fine, MD | ||
| Vol 8, No 1 (2012): January/February | Opioid withdrawal-induced hypomania: A case series | Abstract |
| Navid Khalili, MD, Shahrokh Sardarpour Gudarzi, MD | ||
| Vol 7, No 6 (2011): November/December | Opioid-dependent error processing | Abstract |
| James Fellows-Smith, MBBS, MMedSc, MRCPsych, FRANZCP, FAchAM | ||
| Vol 5, No 3 (2009): May/June | Opioid-induced bowel dysfunction in cancer-related pain: Causes, consequences, and a novel approach for its management | Abstract |
| Peter Holzer, PhD, Sam H. Ahmedzai, BSc, MBChB, FRCP, Norbert Niederle, MD, Petra Leyendecker, PhD, Michael Hopp, MD, Björn Bosse, Statistics (Diploma), Ingrid Spohr, PhD, Karen Reimer, MD | ||
| Vol 15, No 1 (2019): January/February | Opioid-induced constipation in chronic pain: Experience with 180 patients | Abstract |
| Ignacio Velázquez Rivera, MD, Lourdes Velázquez Clavarana, BSc, Pilar García Velasco, BSc, Carmen Melero Ramos, BSc | ||
| Vol 15, No 5 (2019): September/October | Opioid-induced constipation in mixed chronic pain patients: Prevalence and predictors analysis | Abstract |
| Boaz Gedaliahu Samolsky Dekel, MD, PhD, Maria Cristina Sorella, MD, Alessio Vasarri, MD, Alberto Gori, MD, Rita Maria Melotti, MD | ||
| Vol 5, No 3 (2009): May/June | Opioid-induced constipation negatively impacts pain management, productivity, and health-related quality of life: Findings from the National Health and Wellness Survey | Abstract |
| Timothy Bell, MHA, Kathy Annunziata, MA, John B. Leslie, MD, MBA | ||
| Vol 4, No 3 (2008): May/June | Opioid-induced hyperalgesia: Pathophysiology and clinical implications | Abstract |
| Sukanya Mitra, MD, MAMS | ||
| Vol 16, No 5 (2020): September/October | Opioid-related harm in a quaternary pediatric hospital: A 5-year review | Abstract |
| David Greaney, MB BCh, BAO, FRCA, MSc, FJFICMI, Renu Roy, BSP, MSc, RPh, Conor McDonnell, MD, MB BCh, BAO, FFARCSI | ||
| Vol 17, No 3 (2021): May/June | Opioid-related hospitalizations and intravenous drug users: Sociodemographic, spatial, and comorbid associations among hospital inpatients and community-based harm reduction organization participants | Abstract |
| Jacklynn De Leon, BS, MPH, Sheniz Moonie, PhD, Jay J. Shen, PhD, Karen S. Gutierrez, BS, Chad L. Cross, PhD, PStat® | ||
| Vol 2, No 3 (2006): May/June | Opioids and brain imaging | Abstract PDF |
| Shyam Balasubramanian, MBBS, MD, FRCA, Patricia Morley-Forster, MD, FRCPC, Yves Bureau, PhD | ||
| Vol 2, No 2 (2006): March/April | Opioids and Down’s syndrome | Abstract PDF |
| Federica Mafrica, MD, Vincenzo Fodale, MD | ||
| Vol 13, No 1 (2017): January/February | Opioids and nonopioids for postoperative pain control in patients with chronic kidney disease | Abstract |
| Michele Binhas, MD, Julia Egbeola-Martial, MD, Michael D. Kluger MD, MPH, Francoise Roudot-Thoraval, MD, Philippe Grimbert MD, PhD | ||
| Vol 3, No 3 (2007): May/June | Opioids applied topically to painful cutaneous malignant ulcers in a palliative care setting | Abstract PDF |
| Giovambattista Zeppetella, FRCP, Giampiero Porzio, MD, Federica Aielli, MD | ||
| Vol 12, No 1 (2016): January/February | Opioids for outpatients with cancer in their last year of life: A nationwide pharmacoepidemiological study | Abstract |
| Siri Brelin, MD, Olav M. Fredheim, MD, PhD, Jon H. Loge, MD, PhD, Svetlana Skurtveit, PhD, Tom B. Johannesen, MD, PhD, Nina Aass, MD, PhD, Stig Ottesen, MD, PhD, Marianne J. Hjermstad, PhD | ||
| Vol 2, No 1 (2006): January/February | Opioids in the parturient with chronic nonmalignant pain: A retrospective review | Abstract PDF |
| Ibrahim Hadi, MD, FRCPC, Orlando da Silva, MD, FRCPC, Renato Natale, MD, FRCSC, David Boyd, MD, FRCPC, Patricia K. Morley-Forster, MD, FRCPC | ||
| Vol 13, No 6 (2017): November/December - Abuse Deterrent Opioids Special Issue | Opioids with abuse-deterrent properties: A regulatory and technological overview | Abstract |
| J. David Haddox, DDS, MD | ||
| Vol 1, No 4 (2005): September/October | Opioids: The role in headache pharmacotherapy | Abstract PDF |
| Rob Hutchison, PharmD | ||
| Vol 3, No 3 (2007): May/June | Oral naltrexone to enhance analgesia in patients receiving continuous intrathecal morphine for chronic pain: A randomized, double-blind, prospective pilot study | Abstract PDF |
| Scott Hamann, PhD, MD, Paul Sloan, MD | ||
| Vol 1, No 1 (2005): March/April | Oral transmucosal fentanyl citrate for the treatment of breakthrough pain in cancer patients: An overview of its pharmacological and clinical characteristics | Abstract PDF |
| Kyriaki Mystakidou, MD, PhD, Emmanuela Katsouda, MD, Efi Parpa, BA, MA, Marinos L. Tsiatas, MD, PhD, Lambros Vlahos, MD, PhD | ||
| Vol 6, No 3 (2010): May/June | Outcome of acute heroin overdose requiring intensive care unit admission | Abstract |
| Leonidas Grigorakos, MD, PhD, Katerina Sakagianni, MD, Evdoxia Tsigou, MD, George Apostolakos, MD, Giannis Nikolopoulos, MD, Dimitris Veldekis, MD | ||
| Vol 5, No 2 (2009): March/April | Out-of-hospital opioid therapy of palliative care patients with “acute dyspnoea”: A retrospective multicenter investigation | Abstract |
| Christoph H. R. Wiese, MD, Utz E. Bartels, MD, Bernhard M. Graf, MD, Gerd G. Hanekop, MD | ||
| Vol 5, No 4 (2009): July/August | Overcoming obstacles to implementing methadone maintenance therapy for prisoners: Implications for policy and practice | Abstract |
| Michelle McKenzie, MPH, Amy Nunn, MS, ScD, Nickolas D. Zaller, PhD, Alexander R. Bazazi, BA, Josiah D. Rich, MD, MPH | ||
| Vol 14, No 2 (2018): March/April | Oxycodone is safe and effective for general anesthesia | Abstract |
| Stefan Wirz, PhD, MD, Richard K. Ellerkmann, PhD, MD, Martin Soehle, PhD, MD, Christian-Dieter Wirtz, MD | ||
| Vol 12, No 1 (2016): January/February | Oxycodone with an opioid receptor antagonist: A review | Abstract |
| Mellar P. Davis, MD, FCCP, FAAHPM, Harold W. Goforth, MD | ||
| Vol 6, No 1 (2010): January/February | Oxycodone/acetaminophen at low dosage: An alternative pain treatment for patients with rheumatoid arthritis | Abstract |
| William Raffaeli, MD, Claudia Pari, MD, Angelo Corvetta, MD, Donatella Sarti, PhD, Valentina Di Sabatino, MD, Giovanni Biasi, MD, Maurizio Galeazzi, MD | ||
| Vol 14, No 1 (2018): January/February | Oxycodone/naloxone in postoperative pain management of surgical patients | Abstract |
| Ioannis D. Gkegkes, MD, PhD, Evelyn Eleni Minis, MD, Christos Iavazzo, MD, MSc, PhD | ||
| Vol 13, No 3 (2017): May/June | Oxycodone-induced neurotoxicity secondary, to concurrent voriconazole use in a patient with cancer | Abstract |
| Lana Alghothani, MD, Jillian Gustin, MD | ||
| Vol 7, No 3 (2011): May/June | Oxycodone-related side effects: Impact on degree of bother, adherence, pain relief, satisfaction, and quality of life | Abstract |
| Kathryn P. Anastassopoulos, MS, Wing Chow, MPH, PharmD, Stacey J. Ackerman, MSE, PhD, Crisanta Tapia, MHS, Carmela Benson, MS, Myoung S. Kim, MBA, MA, PhD | ||
| Vol 4, No 2 (2008): March/April | OxyContin® use and misuse in three populations: Substance abuse patients, pain patients, and criminal justice participants | Abstract |
| Martha J. Wunsch, MD, Karen L. Cropsey, PsyD, Eleanor D. Campbell, MS, Janet S. Knisely, PhD | ||
| Vol 4, No 3 (2008): May/June | Oxymorphone and oxymorphone extended release: A pharmacotherapeutic review | Abstract |
| Paul Alexander Sloan, MD, Robert L. Barkin, PharmD, MBA | ||
| Vol 2, No 3 (2006): May/June | Pain control for dying patients: Hastening death or ensuring comfort? | Abstract PDF |
| Marshall B. Kapp, JD, MPH | ||
| Vol 11, No 6 (2015): November/December | Pain intensity and interference with functioning and well-being in subgroups of patients with chronic pain treated with once-daily hydrocodone tablets | Abstract |
| Adrian Bartoli, MD, Edward Michna, MD, Ellie He, PhD, Warren Wen, PhD | ||
| Vol 4, No 6 (2008): November/December | Pain management in chronic kidney disease: The pharmacokinetics and pharmacodynamics of hydromorphone and hydromorphone-3-glucuronide in hemodialysis patients | Abstract |
| Sara N. Davison, MD, MHSc (bioethics), FRCP(C), Patrick R. Mayo, PhD, SFO | ||
| Vol 8, No 3 (2012): May/June | Pain management with tapentadol: a better and safer alternative to oxycodone | Abstract |
| Shailendra Kapoor, MD | ||
| Vol 6, No 2 (2010): March/April | PAIN MEDICATION PRESCRIPTION AND BORDERLINE PERSONALITY DISORDER: A PILOT STUDY | Abstract |
| Randy A. Sansone, MD, Michelle Mueller, MD, Amy Mercer, MD, Michael W. Wiederman, MD | ||
| Vol 1, No 1 (2005): March/April | Pain Medicine and Management: Just the Facts | Abstract PDF |
| Gilbert J. Fanciullo, MD, MS | ||
| Vol 7, No 5 (2011): September/October | Pain responsiveness to opioids: Central versus peripheral neuropathic pain | Abstract |
| Howard S. Smith, MD, Patrick D. Meek, PharmD, MSPH | ||
| Vol 8, No 1 (2012): January/February | Palliative care in the management of lung cancer: Analgesic utilization and barriers to optimal pain management | Abstract |
| Charles B. Simone II, MD, Neha Vapiwala, MD, Margaret K. Hampshire, BSN, James M. Metz, MD | ||
| Vol 10, No 3 (2014): May/June | Patient aberrant drug taking behaviors in a large family medicine residency program: A retrospective chart review of screening practices, incidence, and predictors | Abstract |
| Matthew Lewis, PharmD, Christopher M. Herndon, PharmD, BCPS, CPE, John T. Chibnall, PhD | ||
| Vol 16, No 3 (2020): May/June | Patient and pediatric caregiver experiences and expectations about opioid risk education and counselling | Abstract |
| Tanvee Thakur, BPharm, MS, Betty Chewning, PhD | ||
| Vol 15, No 4 (2019): July/August | Patient health literacy and the receipt of opioids in the emergency department | Abstract |
| Joseph A. Dayaa, MS, Montika Bush, PhD, MS, Natalie L. Richmond, BA, Lewis S. Nelson, MD, Timothy F. Platts-Mills, MD, MSc | ||
| Vol 17, No 7 (2021): Special Issue - “Buprenorphine: Clinical and Public Policy Implications" | Patient satisfaction with clinic-based medication pick up: Addressing pharmacy-level challenges to buprenorphine access | Abstract |
| Elizabeth Kolb, MS, Mark Rueth, PharmD | ||
| Vol 6, No 5 (2010): September/October | Patient selection and trialing techniques utilizing low-dose intrathecal morphine for chronic nonmalignant pain: A report of two cases | Abstract |
| Jay S. Grider, DO, PhD, Michael E. Harned, MD, Paul A. Sloan, MD | ||
| Vol 12, No 5 (2016): September/October | Patient-relevant outcomes and health-related quality of life in patients with chronic, severe, noncancer pain treated with tapentadol prolonged release—Using criteria of health technology assessment | Abstract |
| Johannes FX Hofmann, PhD, Arun Lal, MSc, MBA, Maike Steffens, Robert Boettger | ||
| Vol 4, No 1 (2008): January/February | Patients with chronic pain on opioid therapy taking dronabinol: Incidence of false negatives using radioimmunoassay | Abstract |
| Sanjeet Narang, MD, Ajay D. Wasan, MD, MSc, Edgar L. Ross, MD, Edward Michna, MD, Jui-Yuan Chen, MD, Robert N. Jamison, PhD | ||
| Vol 15, No 6 (2019): November/December | Patterns in opioid prescription in the United States by region and prescribers over a 4-year period | Abstract |
| Luisa M. Bigal, BA, Kristen Bibeau, PhD, Stephanie Dumbar, PhD | ||
| Vol 9, No 5 (2013): September/October | Patterns of care and side effects for patients prescribed methadone for treatment of chronic pain | Abstract |
| Tara A. Macey, PhD, Melissa B. Weimer, DO, MCR, Elizabeth M. Grimaldi, BA, Steven K. Dobscha, MD, Benjamin J. Morasco, PhD | ||
| Vol 16, No 1 (2020): January/February | Patterns of heroin use following index prescription opioid exposure | Abstract |
| Scott M. Sexton, PharmD, Christopher M. Herndon, PharmD, BCACP, Jordan D. Sinclair, PharmD | ||
| Vol 3, No 1 (2007): January/February | Patterns of illicit drug use and retention in a methadone program: A longitudinal study | Abstract PDF |
| Ingrid Davstad, MA, Marlene Stenbacka, PhD, Anders Leifman, MSE, Olof Beck, PhD, Seher Korkmaz, MD, PhD, Anders Romelsjo, MD, PhD | ||
| Vol 8, No 1 (2012): January/February | PCA-derived factors that may be predictive of postoperative pain in pediatric patients: A possible role for the PCA ratio | Abstract |
| Conor Mc Donnell, MD, MB, Carolyne Pehora, MN, Mark W. Crawford, MBBS | ||
| Vol 16, No 1 (2020): January/February | Perceived patient benefits from using prescription opioids and other therapies to manage persistent pain | Abstract |
| Farzana Mitra, MD, MBBS, FRACGP, DA, Dip. AC, Torres Woolley, PhD, MPHTM | ||
| Vol 15, No 2 (2019): March/April | Perceptions of opioid misuse and chronic pain: A qualitative assessment of Rhode Island commercial fishing captains | Abstract |
| Travis Brown, BS, Paul George, MD, MHPE | ||
| Vol 10, No 1 (2014): January/February | Perioperative dilemma: Challenges of the management of a patient on mega doses of morphine and methadone | Abstract |
| Alan David Kaye, MD, PhD, DABA, DABPM, DABIPP, Aymen A. Alian, MD, Nalini Vadivelu, MD, Keun Sam Chung, MD | ||
| Vol 17, No 3 (2021): May/June | Perioperative gabapentinoid use lowers short-term opioid consumption following lower limb arthroplasty: Systematic review and meta-analysis | Abstract |
| Ryan Campbell, MD, Jacqueline Nguyen Khuong, MD, Zhengyang Liu, BBiomed, Carla Borg, MD, Sarah Jackson, BBiomed, Dhruvesh M. Ramson, MBBS (Hons), Juliana Kok, MD, Ned Douglas, MD, Jahan C. Penny-Dimri, MBBS (Hons), Luke A. Perry, MBBS (Hons) | ||
| Vol 2, No 6 (2006): November/December | Perioperative management of opioid-tolerant chronic pain patients | Abstract PDF |
| Dima Rozen, MD, Noah P. DeGaetano, MD | ||
| Vol 16, No 6 (2020): November/December | Perioperative methadone prescribing and association with respiratory depression | Abstract |
| Sarah E. Bova, PharmD, Rachel M. Kruer, PharmD, Suzanne A. Nesbit, PharmD, Michael C. Grant, MD, Andrew S. Jarrell, PharmD | ||
| Vol 17, No 7 (2021): Special Issue - “Buprenorphine: Clinical and Public Policy Implications" | Perioperative outcomes for patients on chronic buprenorphine undergoing spine surgery: A case series | Abstract |
| Ashley L. Sharp, MD, Stephanie Gilbert, MD, Danielle N. Perez, MD, Kerstin Kolodzie, MD, PhD, MAS, Matthias Behrends, MD | ||
| Vol 17, No 7 (2021): Special Issue - “Buprenorphine: Clinical and Public Policy Implications" | Perioperative pain management and outcomes in patients who discontinued or continued pre-existing buprenorphine therapy | Abstract |
| Aamer Attaar, PharmD, BCPS, Molly Curran, PharmD, BCPS, BCCCP, Lyndsi Meyenburg, PharmD, BCPS, Richard Bottner, DHA, PA-C, Clarissa Johnston, MD, Kirsten Roberts Mason, PharmD, BCPS | ||
| Vol 10, No 6 (2014): November/December | Perioperative substance use disorder, opioid diversion, and opioid misuse by a medical professional undergoing orthopedic surgery | Abstract |
| Dermot Maher, MD, MS, Michael Kissen, MD, Itai Danovitch, MD, MBA, Roya Yumul, MD, PhD, Charles Louy, PhD, MD | ||
| Vol 7, No 1 (2011): January/February | Peripheral opioid receptor agonists for analgesia: A comprehensive review | Abstract |
| Nalini Vadivelu, MD, Sukanya Mitra, MD, Roberta L. Hines, MD | ||
| Vol 3, No 4 (2007): July/August | Personality traits and sensitivity to pain in male chronic opioid addicts | Abstract |
| Elon Eisenberg, MD, Doron Cohen, MA, Eli Lawental, PhD, Dorit Pud, PhD | ||
| Vol 3, No 6 (2007): November/December | Pharmacist-physician collaboration in pain management practice | Abstract |
| Jennifer M. Strickland, PharmD, BCPS, Angela Huskey, PharmD, David B. Brushwood, RPh, JD | ||
| Vol 11, No 4 (2015): July/August | Pharmacoepidemiology of opiate use in the neonatal ICU: Increasing cumulative doses and iatrogenic opiate withdrawal | Abstract |
| Tamorah Lewis, MD, Betty Luan Erfe, BS, Tarrah Ezell, BS, Estelle Gauda, MD | ||
| Vol 9, No 4 (2013): July/August | Pharmacokinetic evaluation of tapentadol extended-release tablets in healthy subjects | Abstract |
| Peter N. Zannikos, PhD, Johan W. Smit, PhD, Hans-Jürgen Stahlberg, MD, Birger Wenge, PhD, Vera M. Hillewaert, MSc, Mila S. Etropolski, MD | ||
| Vol 6, No 1 (2010): January/February | Pharmacokinetics of intranasal fentanyl spray in patients with cancer and breakthrough pain | Abstract |
| Stein Kaasa, MD, PhD, Kristin Moksnes, MD, Thomas Nolte, MD, Daniele Lefebvre-Kuntz, MD, Lars Popper, MS, PhD, Hans Georg Kress, MD, PhD | ||
| Vol 4, No 2 (2008): March/April | Pharmacokinetics of oral tramadol in patients with liver cancer | Abstract |
| Hassan Ibraheem Mohamed Kotb, MD, Ihab Ahmed Fouad, PhD, Khaled Mohamed Fares, MD, Mostafa Galal Mostafa, MD, Ahmad M. Abd El-Rahman, MSc | ||
| Vol 10, No 5 (2014): September/October | Pharmacological and toxicological profile of opioid-treated, chronic low back pain patients entering a mindfulness intervention randomized controlled trial | Abstract |
| Aleksandra Zgierska, MD, PhD, Margaret L. Wallace, PharmD, BCACP, Cindy A. Burzinski, MS, Jennifer Cox, BS, Miroslav Backonja, MD | ||
| Vol 5, No 2 (2009): March/April | Pharmacological management of cancer pain | Abstract |
| Marcos L. Montagnini, MD, FACP, Carolyn R. Zaleon, PharmD | ||
| Vol 16, No 5 (2020): September/October | Pharmacy multidisciplinary stewardship program for high-risk patients prescribed opioids in an academic clinic | Abstract |
| Yvette Hellier, PharmD, Machelle Wilson, PhD, Angela Leahy, PharmD, Kevin Burnham, MD | ||
| Vol 14, No 5 (2018): September/October | Pharmacy-related theft of controlled substances: RxPATROL® findings | Abstract |
| Jennifer G. Erensen, MPH, J. David Haddox, DDS, MD, Maigh S. Attre, Luis N. Bauza, MS, CPP | ||
| Vol 10, No 4 (2014): July/August | Photos from International Conference on Opioids, June 8-10, 2014 | Abstract |
| JOM Editors | ||
| Vol 12, No 4 (2016): July/August | Physician conviction for prescription related deaths: How will this affect the opioid debate? | Abstract |
| Humair Rana, MD, Brian Braithwaite, MD | ||
| Vol 8, No 1 (2012): January/February | Physician identification of opioid diversion: A difficult diagnosis | Abstract |
| Gary M. Reisfield, MD, Paul A. Sloan, MD | ||
| Vol 9, No 6 (2013): November/December | Physician management of moderate-to-severe acute pain: Results from the Physicians Partnering Against Pain (P3) Study | Abstract |
| Bill H. McCarberg, MD, Aarti A. Patel, PharmD, MBA, Carmela J. Benson, MS, Samir H. Mody, PharmD, MBA, Wing Chow, PharmD, MPH, Carla L. Zema, PhD, Gary J. Vorsanger, PhD, MD, Myoung S. Kim, PhD, MBA, MA | ||
| Vol 8, No 2 (2012): March/April | Physician survey examining the impact of an educational tool for responsible opioid prescribing | Abstract |
| Aaron Young, PhD, Kelly C. Alfred, MS, Philip P. Davignon, MA, LaSharn M. Hughes, MBA, Lisa A. Robin, MLA, Humayun J. Chaudhry, DO | ||
| Vol 3, No 4 (2007): July/August | Physician-related barriers to cancer pain management with opioid analgesics: A systematic review | Abstract |
| Ramune Jacobsen, MS, MPH, Per Sjøgren, MD, DMS, Claus Møldrup, PhD, Lona Christrup, PhD | ||
| Vol 5, No 3 (2009): May/June | Physicians’ pain management confidence versus competence | Abstract |
| Mark A. Douglass, PharmD, Gail M. Sanchez, PharmD, BCPS, Daniel P. Alford, MD, MPH, Gail Wilkes, RNC, MS, AOCN, Jeffrey L. Greenwald, MD | ||
| Vol 7, No 6 (2011): November/December | Plasma cyclic guanosine 3′,5′-monophosphate levels: A marker of glutamate-nitric oxide-guanyl cyclase activity? | Abstract |
| Thomas Engelhardt, MD, PhD, FRCA, Christian Zaarour, MD, Mark W. Crawford, MBBS, FRCPC | ||
| Vol 16, No 4 (2020): July/August | Polysubstance abuse associated with more frequent opioid use among patients in rural primary care settings | Abstract |
| David L. Albright, PhD, Justin McDaniel, PhD, Kirsten Laha-Walsh, MSW, Beth Morrison, MS, Shanna McIntosh, MS | ||
| Vol 2, No 1 (2006): January/February | Poor pain relief and possible toxicity from high-dose intrathecal opioid treatment: Report of two cases | Abstract PDF |
| Anca Popescu, MD, Rajorshi Mitra, MD, Jane Ballantyne, MD, FRCA | ||
| Vol 7, No 3 (2011): May/June | Positive and negative subjective effects of extended-release oxymorphone versus controlled-release oxycodone in recreational opioid users | Abstract |
| Kerri A. Schoedel, PhD, Stephen McMorn, PhD, Bijan Chakraborty, MStat, Susan L. Potts, MS, Kathleen Zerbe, RN, Edward M. Sellers, MD, PhD | ||
| Vol 11, No 3 (2015): May/June | Positive subjective measures in abuse liability studies and real-world nonmedical use: Potential impact of abuse-deterrent opioids on rates of nonmedical use and associated healthcare costs | Abstract |
| Alan G. White, PhD, Joseph LeCates, PhD, Howard G. Birnbaum, PhD, Wendy Cheng, MPH, MPhil, Carl L. Roland, PharmD, MS, Jack Mardekian, PhD | ||
| Vol 15, No 2 (2019): March/April | Postlaparotomy pain management: Comparison of patient-controlled analgesia pump alone, with subcutaneous bupivacaine infusion, or with injection of liposomal bupivacaine suspension | Abstract |
| Harish M. Yalmanchili, MD, Stephanie N. Buchanan, MD, Lowell W. Chambers, MD, FACS, Jantzen D. Thorns, MD, Nicholas A. McKenzie, MD, Alisha D. Reiss, MD, Maurice P. Page, MD, Victor V. Dizon, DO, FACOS, Sheila E. Brooks, RN, BSN, Lynn E. Shaffer, PhD, Scott T. Lovald, PhD, Thomas H. Hartranft, MD, FACS, Phillip D. Price, MD, FACS | ||
| Vol 5, No 6 (2009): November/December | Postoperative analgesia after radical prostatectomy with high-dose intrathecal morphine and intravenous naloxone: A retrospective review | Abstract |
| Annette Rebel, MD, Paul Sloan, MD, Michael Andrykowski, PhD | ||
| Vol 13, No 4 (2017): July/August | Postoperative pain scores and opioid consumption in opioid-dependent patients with cancer after intraoperative remifentanil analgesia: A prospective case-controlled study | Abstract |
| Cyrus Motamed, MD, Juliette Audibert, MD, Aline Albi-Feldzer, MD, Gaelle Bouroche, MD, Christian Jayr, MD, PhD | ||
| Vol 15, No 4 (2019): July/August | Postoperative surgical trainee opioid prescribing practices (POST-OPP): A national survey | Abstract |
| David J. Hall, MD, Juan C. Mira, MD, Melissa R. Hoffman, MD, ND, Hari B. Keshava, MD, MS, Kevin R. Olsen, MD, John C. Hardaway, MD, PhD, Patrick W. Underwood, MD, Kristy L. Hawley, MD, MPH, Patricia L. Turner, MD, Ajay B. Antony, MD, Terrie Vasilopoulos, PhD, Nicolas J. Mouawad, MD, MPH, MBA | ||
| Vol 8, No 4 (2012): July/August | Postsurgical patient-controlled opioid self-administration is greater in hospitalized abstinent smokers than nonsmokers | Abstract |
| Caren L. Steinmiller, PhD, Christina Diederichs, BS, Timothy A. Roehrs, PhD, Maren Hyde-Nolan, MS, Thomas Roth, PhD, Mark K. Greenwald, PhD | ||
| Vol 7, No 5 (2011): September/October | Potency ratio of hydromorphone and diacetylmorphine in substitution treatment for long-term opioid dependency | Abstract |
| Eugenia Oviedo-Joekes, PhD, David C. Marsh, MD, Daphne Guh, MSc, Suzanne Brissette, MD, Martin T. Schechter, MD, PhD | ||
| Vol 10, No 1 (2014): January/February | Potential impact of abrupt opioid therapy discontinuation in the management of chronic pain: A pilot study on patient perspective | Abstract |
| Joy Hao, MD, PhD, David Lucido, PhD, Ricardo A. Cruciani, MD, PhD | ||
| Vol 17, No 4 (2021): July/August | Potential innovative targets in the treatment of pain: Combined μ and NOP receptor agonists | Abstract |
| Raphael J. Leo, MA, MD | ||
| Vol 16, No 3 (2020): May/June | Potential pharmacological perspectives for the treatment/prevention of the SARS-COV-2 infection in opioid dependent patients | Abstract |
| Maurizio Coppola, MD, Raffaella Mondola, MD | ||
| Vol 4, No 5 (2008): September/October | Prediction of withdrawal symptoms during opioid detoxification | Abstract |
| Boukje A. G. Dijkstra, MSc, Paul F. M. Krabbe, PhD, Cor A. J. De Jong, MD, PhD, Cees P. F. van der Staak, PhD | ||
| Vol 15, No 3 (2019): May/June | Pre-existing opioid use disorder and postoperative outcomes after appendectomy or cholecystectomy: A multi-state analysis, 2007-2014 | Abstract |
| Alina Boltunova, MD, Robert S. White, MD, MS, Selaiman Noori, MD, Stephanie A. Chen, BA, Licia K. Gaber-Baylis, BA, Roniel Weinberg, MD | ||
| Vol 9, No 1 (2013): January/February | Preliminary data on a new opioid risk assessment measure: The Brief Risk Interview | Abstract |
| Ted Jones, PhD, Todd Moore, PhD | ||
| Vol 8, No 4 (2012): July/August | Prepping, another cause for diversion of opioids | Abstract |
| Frank A. Kunkel, MD, Isabel Ahrendt | ||
| Vol 14, No 5 (2018): September/October | Prescribers' perceptions on the impact of hydrocodone rescheduling on geriatric pain management: A qualitative study | Abstract |
| Julianna Fernandez, PharmD, BCPS, CGP, James Douglas Thornton, PhD, PharmD, BCPS, Sanika Rege, MS, Benjamin Lewing, MS, Shweta Bapat, BPharm, Qingqing Xu, MS, Marc L. Fleming, PhD, MPH, RPH | ||
| Vol 3, No 6 (2007): November/December | Prescribing opioids in renal failure | Abstract |
| Joanne Droney, MB, BCh, MRCP(I), Jeremy Levy, PhD, FRCP, Columba Quigley, FRCP | ||
| Vol 5, No 4 (2009): July/August | Prescription drug fatalities among women in rural Virginia: A study of medical examiner cases | Abstract |
| Martha J. Wunsch, MD, Kent Nakamoto, PhD, Paul A. Nuzzo, MA, George Behonick, PhD, William Massello, MD, Sharon L. Walsh, PhD | ||
| Vol 2, No 5 (2006): September/October | Prescription opioid abuse among drug-involved street-based sex workers | Abstract PDF |
| Hilary L. Surratt, PhD, James A. Inciardi, PhD, Steven P.q Kurtz, PhD | ||
| Vol 1, No 2 (2005): May/June | Prescription opioid dependence and treatment with methadone in pregnancy | Abstract PDF |
| Stephanie C. Eken Sander, MD, Lon R. Hays, MD, MBA | ||
| Vol 15, No 4 (2019): July/August | Prescription Opioid Misuse Index in sickle cell patients: A brief questionnaire to assess at-risk for opioid abuse | Abstract |
| Wally R. Smith, MD, Donna K. McClish, PhD, John D. Roberts, MD, Osama Kandalaft, MD, Bassam Dahman, PhD, Janet Knisely, PhD, James Levenson, MD, Susan Roseff, MD, Imo P. Aisiku, MD | ||
| Vol 16, No 6 (2020): November/December | Prescription opioid use duration and beliefs about pain and pain medication in primary care patients | Abstract |
| Philip Day, PhD, Scott Secrest, MPH, Dawn Davis, MD, Joanne Salas, MPH, Carissa van den Berk-Clark, PhD, MSW, Neelima Kale, PhD, MD, MBA, Catherine Hearing, MPH, F. David Schneider, MD, MSPH, Jeffrey F. Scherrer, PhD, ARCHNet Investigators | ||
| Vol 17, No 3 (2021): May/June | Prescription opioid use during pregnancy and risk for preterm birth or term low birthweight | Abstract |
| Julia D. Interrante, MPH, Stacey L. P. Scroggs, PhD, Carol J. Hogue, PhD, Jan M. Friedman, MD, Jennita Reefhuis, PhD, Michael W. Jann, PharmD, Cheryl S. Broussard, PhD, National Birth Defects Prevention Study | ||
| Vol 4, No 2 (2008): March/April | Prescription opioid use in the rural Appalachia: A community-based study | Abstract |
| Jennifer R. Havens, PhD, MPH, Robert Walker, MSW, LCSW, Carl G. Leukefeld, DSW | ||
| Vol 16, No 5 (2020): September/October | Prescriptions for opioids and opioid-included polypharmacy: An analysis of the National Hospital Ambulatory Medical Care Survey | Abstract |
| Jessica C. Rivera, MD, PhD | ||
| Vol 17, No 1 (2021): January/February | Presence of opioid safety initiatives, prescribing patterns for opioid and naloxone, and perceived barriers to prescribing naloxone: Cross-sectional survey results based on practice type, scope, and location | Abstract |
| Lynn R. Kohan, MD, Dalia Elmofty, MD, Israel Pena, MD, Chuanhong Liao, MS | ||
| Vol 3, No 2 (2007): March/April | Prevalence and characteristics of breakthrough pain in patients receiving opioids for chronic back pain in pain specialty clinics | Abstract PDF |
| Daniel S. Bennett, MD, Steven Simon, MD, RPh, Michael Brennan, MD, Steven A. Shoemaker, MD | ||
| Vol 12, No 4 (2016): July/August | Prevalence and correlates of coprescribing anxiolytic medications with extensive prescription opioid use in Veterans Health Administration patients with metastatic cancer | Abstract |
| Declan T. Barry, PhD, Mehmet Sofuoglu, MD, Robert D. Kerns, PhD, Ilse R. Wiechers, MD, Robert A. Rosenheck, MD | ||
| Vol 9, No 3 (2013): May/June | Prevalence and cost of diagnosed opioid abuse in a privately insured population in the United States | Abstract |
| Carl L. Roland, PharmD, Ashish V. Joshi, PhD, Jack Mardekian, PhD, Steven C. Walden, PharmD, MBA, James Harnett, PharmD, MS | ||
| Vol 3, No 3 (2007): May/June | Prevalence of opioid dependence in spine surgery patients and correlation with length of stay | Abstract PDF |
| Mohammad Sami Walid, MD, PhD, Leon Hyer, PhD, Mohammed Ajjan, MD, Aaron C. M. Barth, Joe Sam Robinson, Jr, MD | ||
| Vol 4, No 4 (2008): July/August | Prevalence of opioid dispensings and concurrent gastrointestinal medications in an elderly population from Ontario, Canada | Abstract |
| Rachel Williams, PhD, MS, Nevzeta Bosnic, BA, Ashlee W. Duncan, PhD, MS, Michael Brogan, BA, Suzanne F. Cook, PhD | ||
| Vol 10, No 2 (2014): March/April | Preventing and managing aberrant drug-related behavior in primary care: Systematic review of outcomes evidence | Abstract |
| Charles E. Argoff, MD, Meldon Kahan, MD, Edward M. Sellers, MD | ||
| Vol 7, No 2 (2011): March/April | Primary care physician opinion survey on FDA Opioid Risk Evaluation and Mitigation Strategies | Abstract |
| Kieran A. Slevin, MD, Michael A. Ashburn, MD, MPH | ||
| Vol 15, No 3 (2019): May/June | Primary care physicians’ perspectives on Veterans who obtain prescription opioids from multiple healthcare systems | Abstract |
| Felicia R. Bixler, MS, Thomas R. Radomski, MD, MS, Susan L. Zickmund, PhD, KatieLynn M. Roman, BA, Leslie R. M. Hausmann, PhD, Carolyn T. Thorpe, PhD, MPH, Jennifer A. Hale, BS, Florentina E. Sileanu, MS, Walid F. Gellad, MD, MPH | ||
| Vol 12, No 6 (2016): November/December | Primary care providers’ prescribing practices of opioid controlled substances | Abstract |
| Lisa B. E. Shields, MD, Soraya Nasraty, MD, MMM, CPE, Alisha D. Bell, MSN, RN, CPN, Anil N. Vinayakan, MD, Raghunath S. Gudibanda, MD, Steven T. Hester, MD, MBA, Joshua T. Honaker, MD, FAAP | ||
| Vol 7, No 6 (2011): November/December | Primary care survey of the value and effectiveness of the Washington State Opioid Dosing Guideline | Abstract |
| Josiah S. Morse, MPH, Hal Stockbridge, MD, MPH, Kathleen B. Egan, MPH, Jaymie Mai, PharmD, Thomas Wickizer, PhD, Gary M. Franklin, MD, MPH | ||
| Vol 2, No 1 (2006): January/February | Problematic terminology for problematic drug use | Abstract PDF |
| David Cowan, MD, BSc (Hons), PhD | ||
| Vol 1, No 1 (2005): March/April | Progress in pain management: Where are we? | Abstract PDF |
| Frederick J. Goldstein, PhD, FCP | ||
| Vol 13, No 5 (2017): September/October | Projecting the cost, utilization, and patient care impact of prescribing extended release non-abuse-deterrent opioids to chronic pain patients | Abstract |
| Mihran Ara Yenikomshian, MBA, Alan G. White, PhD, Michael E. Carson, BS, Louis P. Garrison, PhD, Gary M. Oderda, PharmD, MPH, Joseph E. Biskupiak, PhD, MBA, Patrick R. Hlavacek, MPH, Carl L. Roland, PharmD, MS | ||
| Vol 9, No 4 (2013): July/August | Prolonged QT interval by methadone: Relevance for daily practice? A prospective study in patients with cancer and noncancer pain | Abstract |
| Marieke H. J. van den Beuken-van Everdingen, MD, PhD, José W. Geurts, MSc, Jacob Patijn, MD, PhD | ||
| Vol 14, No 4 (2018): July/August | Provider reasons for discontinuing long-term opioid therapy following aberrant urine drug tests differ based on the type of substance identified | Abstract |
| Jessica J. Wyse, PhD, Benjamin J. Morasco, PhD, Steven K. Dobscha, MD, Michael I. Demidenko, BS, Thomas H. A. Meath, MPH, Travis I. Lovejoy, PhD, MPH | ||
| Vol 3, No 2 (2007): March/April | Psychological factors as predictors of opioid abuse and illicit drug use in chronic pain patients | Abstract PDF |
| Laxmaiah Manchikanti, MD, James Giordano, PhD, Mark V. Boswell, MD, PhD, Bert Fellows, MA, Rajeev Manchukonda, BDS, Vidyasagar Pampati, MSc | ||
| Vol 6, No 3 (2010): May/June | Psychosocial distress in patients treated for cancer pain: A prospective observational study | Abstract |
| Sean O’Mahony, MB BCh, BAO, Joseph Lucien Goulet, PhD, Richard Payne, MD | ||
| Vol 14, No 5 (2018): September/October | Psychosocial interventions for chronic pain and comorbid prescription opioid use disorders: A narrative review of the literature | Abstract |
| Valerie Hruschak, MSW, Gerald Cochran, PhD, Ajay D. Wasan, MD, MSc | ||
| Vol 1, No 2 (2005): May/June | PUMP TAMPERING POSSIBLE BY PATIENTS IN OPIOID ADMINISTRATION | Abstract PDF |
| Richard A. DeVito, Jr. | ||
| Vol 11, No 6 (2015): November/December | Quantification of oxycodone and morphine analytes in urine: Assessment of adherence | Abstract |
| Michael E. M. Larson, PhD, Richard L. Berg, MS, Joyce Flanagan, PhD | ||
| Vol 15, No 3 (2019): May/June | Race and ethnicity: Not factors in the prescribing of hydrocodone- and codeine-containing products in two pediatric emergency departments | Abstract |
| Chris A. Rees, MD, MPH, Melanie Brooke Bernhardt, PharmD, Elizabeth A. Camp, PhD, Jessica S. Lin, BA, Corrie E. Chumpitazi, MD, MS | ||
| Vol 11, No 2 (2015): March/April | Randomized double-blind placebo trial of duloxetine in perioperative spine patients | Abstract |
| Lee Hyer, PhD, ABPP, Ciera Scott, MS, NCC, Christine M. Mullen, MA, Laura C. McKenzie, BA, Joe Sam Robinson Jr, MD | ||
| Vol 17, No 7 (2021): Special Issue - “Buprenorphine: Clinical and Public Policy Implications" | Rapid microinduction of sublingual buprenorphine from methadone in an outpatient setting: “A case series” | Abstract |
| Gurpreet Singh, MBBS, Jaya Sri Konakanchi, MBBS, Brandon Betsch, Aastha Thapa, Roopa Sethi, MD | ||
| Vol 9, No 3 (2013): May/June | Rationale and design of the Oxycodone Users Registry: A prospective, multicenter registry of patients with nonmalignant pain | Abstract |
| Myoung Kim, PhD, Wing Chow, PharmD, MPH, Carmela Benson, MS | ||
| Vol 6, No 4 (2010): July/August | Rationales behind the choice of administration form with fentanyl: Delphi survey among Danish general practitioners | Abstract |
| Ramune Jacobsen, PhD, Claus Møldrup, PhD, Lona Christrup, PhD | ||
| Vol 13, No 6 (2017): November/December - Abuse Deterrent Opioids Special Issue | Reality and responsibility revisited: Stakeholder accountability in the effort to develop safer opioids | Abstract |
| Steven D. Passik, PhD, Howard A. Heit, MD, Michael DeGeorge, PharmD | ||
| Vol 2, No 3 (2006): May/June | Reality and responsibility: A commentary on the treatment of pain and suffering in a drug-using society | Abstract PDF |
| Steven D. Passik, PhD, Howard Heit, MD, FACP, FASAM, Kenneth L. Kirsh, PhD | ||
| Vol 12, No 4 (2016): July/August | Reducing the community-prescribed opioid load: A public health approach to the opioid epidemic | Abstract |
| Julia Lew, MS1, BSc, Kieran Moore, MD, CCFP(EM), FCFP, MPH, DTM&H, FRCPC | ||
| Vol 17, No 2 (2021): March/April | Reduction in Schedule II opioid prescribing by primary care providers, orthopedic and general surgeons, and pain management specialists following the implementation of a State House Bill and an Institutional Controlled Substance Task Force | Abstract |
| Lisa B. E. Shields, MD, Timothy A. Johnson, BS, Michael W. Daniels, MS, Alisha Bell, MSN, RN, CPN, Diane M. Siemens, PharmD, James T. Jennings, MD, MBA, Steven T. Hester, MD, MBA, Joshua T. Honaker, MD, MBA, FAAP | ||
| Vol 17, No 4 (2021): July/August | Reduction of opioid use using regional anesthetic blocks after inguinal hernia repair in a high risk, safety net population | Abstract |
| Sayeeda Rab, BS, Sudeepti Vedula, BS, Aziz M. Merchant, MD, FACS | ||
| Vol 6, No 5 (2010): September/October | Reference intervals: A novel approach to detect drug abuse in a pain patient population | Abstract |
| Amadeo Pesce, PhD, DABCC, Cameron West, PhD, Robert West, MS, Bridgit Crews, PhD, Charles Mikel, PhD, Perla Almazan, CLS, MT (ASCP), Sergey Latyshev, MS, Murray Rosenthal, DO, FAPA, Paul Horn, PhD | ||
| Vol 11, No 5 (2015): September/October | Relationship between change in pain intensity and functional outcomes in patients with chronic pain receiving twice daily extended-release hydrocodone bitartrate | Abstract |
| Charles Argoff, MD, Paul Arnstein, RN, PhD, FAAN, Steven Stanos, DO, Cynthia Y. Robinson, PhD, Bradley S. Galer, MD, Errol Gould, PhD, Arnold Gammaitoni, PharmD | ||
| Vol 4, No 1 (2008): January/February | Relationship between fentanyl dosage and immune function in the postoperative period | Abstract |
| Israel Z. Yardeni, MD, Benzion Beilin, MD, Eduard Mayburd, MD, Yifat Alcalay, MSc, Hanna Bessler, PhD | ||
| Vol 5, No 4 (2009): July/August | Relationship between rate of infusion and reinforcing strength of oxycodone in humans | Abstract |
| Sandra D. Comer, PhD, Judy B. Ashworth, MD, Maria A. Sullivan, MD, PhD, Suzanne K. Vosburg, PhD, Phillip A. Saccone, BS, Richard W. Foltin, PhD | ||
| Vol 2, No 4 (2006): July/August | Relative abuse potential of opioid formulations in Canada: A structured field study | Abstract PDF |
| Edward M. Sellers, MD, PhD, FRCPC, Reinhard Schuller, MSc, Myroslava K. Romach, MD, G. L. A. Horbay, PhD | ||
| Vol 10, No 4 (2014): July/August | Remifentanil target-controlled infusion: A safe rescue protocol for unexpected severe postoperative pain | Abstract |
| Cyrus Motamed, MD, Grégoire Weil, MD, Frederic Deschamps, MD, Valérie Billard, MD | ||
| Vol 3, No 5 (2007): September/October | Remifentanil versus remifentanil with paracervical block on plasma remifentanil concentrations and pulmonary function tests for transvaginal ultrasound-guided oocyte retrieval | Abstract |
| Berrin Gunaydin, MD, PhD, I. Kivilcim Ozulgen, MD, Ertan Ozturk, MD, Zeki T. Tekgul, MD, Kadir Kaya, MD | ||
| Vol 2, No 4 (2006): July/August | Renal effects of opioid exposure: Considerations for therapeutic use | Abstract PDF |
| Kalpna Gupta, PhD, Marc L. Weber, MD | ||
| Vol 8, No 1 (2012): January/February | Report of an HIV clinic-based pain management program and utilization of health status and health service by HIV patients | Abstract |
| Ahashta Johnson, MD, Kathleen DiGangi Condon, ANP-BC, MS, MA, Ann Celeste Mapas-Dimaya, MD, Judith Schrager, RN, PMHNP-BC, Robert Grossberg, MD, Rosalyn Gonzalez, BA, CASAC, Sean O’Mahony, MB, BCh, BAO, MS | ||
| Vol 9, No 2 (2013): March/April | Reported side effects, bother, satisfaction, and adherence in patients taking hydrocodone for non-cancer pain | Abstract |
| Kathryn P Anastassopoulos, MS, Wing Chow, PharmD, Crisanta I. Tapia, MHS, Rebecca Baik, BS, Bruce Moskowitz, MD, Myoung S. Kim, PhD | ||
| Vol 8, No 5 (2012): September/October | Rethinking methadone for the management of chronic pain | Details |
| Gary M. Reisfield, MD, Paul A. Sloan, MD | ||
| Vol 17, No 4 (2021): July/August | Retrospective study of the effect of opioid prescribing guidelines on prescribing practices in pediatric orthopedic sports medicine patients having knee surgery: A single institution's experience | Abstract |
| Jeffrey G. Stepan, MD, MSc, Christine Goodbody, MD, Kanupriya Kumar, MD, Kathryn DelPizzo, MD, Peter Fabricant, MD, MPH, Pamela Wendel, MD | ||
| Vol 10, No 4 (2014): July/August | Review article. Buprenorphine in the workers' compensation setting | Abstract |
| Stephen Colameco, MD, MEd, FASAM, Mel Pohl, MD, FASAM | ||
| Vol 10, No 4 (2014): July/August | Review article. Opioid analgesics: Does potency matter? | Abstract |
| Steven D. Passik, PhD, Lynn Webster, MD | ||
| Vol 9, No 1 (2013): January/February | Review article. Pharmacokinetic evaluation of hydrocodone/acetaminophen for pain management | Abstract |
| Aarti Singla, MD, Paul Sloan, MD | ||
| Vol 12, No 4 (2016): July/August | Review of perioperative pain management of opioid-dependent patients | Abstract |
| Nalini Vadivelu, MD, Sukanya Mitra, MD, MAMS, Alice M. Kai, BA, Gopal Kodumudi, MS, Karina Gritsenko, MD | ||
| Vol 17, No 7 (2021): Special Issue - “Buprenorphine: Clinical and Public Policy Implications" | Review of the adaptations in opioid agonist treatment during the COVID-19 pandemic: Focus on buprenorphine-based treatment | Abstract |
| Abhishek Ghosh, MD, DM, Chandrima Naskar, MD, Fazl-e Roub, MD, DM, Debasish Basu, MD, DNB, MAMS | ||
| Vol 12, No 5 (2016): September/October | Rhode Island Board of Medical Licensure and Discipline: Illustration of the disciplinary process as it pertains to cases involving opioid prescribing | Abstract |
| James V. McDonald, MD, MPH | ||
| Vol 8, No 5 (2012): September/October | Risk assessment and counseling behaviors of healthcare professionals managing patients with chronic pain: A national multifaceted assessment of physicians, pharmacists, and their patients | Abstract |
| Gregory D. Salinas, PhD, Debi Susalka, B. Stephen Burton, MS, Nancy Roepke, MBA, Kimberly Evanyo, David Biondi, DO, Susan Nicholson, MD | ||
| Vol 8, No 6 (2012): November/December | Risk factors for drug diversion in a pain clinic patient population | Abstract |
| Mary Jean Walker, DNP, Lynn R. Webster, MD | ||
| Vol 12, No 3 (2016): May/June | Risk factors for opioid misuse in adolescents and young adults with focus on oncology setting | Abstract |
| Kelly R. Peck, MA, Jennifer Harman Ehrentraut, PhD, Doralina L. Anghelescu, MD | ||
| Vol 16, No 1 (2020): January/February | Risk of chronic opioid use in older persons with pre-existing anxiety | Abstract |
| Anna K. Moffat, PhD, Nicole L. Pratt, PhD, Mhairi Kerr, MSc, Lisa M. Kalisch Ellett, PhD, Elizabeth E. Roughead, PhD | ||
| Vol 3, No 4 (2007): July/August | Roadblock on the health IT superhighway: E-prescribing and the controlled substances act | Abstract |
| Kate L. Lapane, PhD, Brian J. Quilliam, PhD, David D. Dore, PharmD | ||
| Vol 7, No 5 (2011): September/October | Role of codeine in palliative care | Abstract |
| Eric Prommer, MD | ||
| Vol 7, No 4 (2011): July/August | Role of codeine in palliative care | Abstract |
| Eric Prommer, MD | ||
| Vol 1, No 4 (2005): September/October | Role of gabapentin in postoperative pain | Abstract PDF |
| Alparslan Turan, MD | ||
| Vol 4, No 3 (2008): May/June | Role of patient-based health status outcome measurements in opioid management for low back pain | Abstract |
| Vinod K. Podichetty, MD, MS, Eric S. Varley, DO, Michelle Secic, MS | ||
| 501 - 750 of 950 Items | << < 1 2 3 4 > >> | |